Mission Produce $96 million IPO
Davis Polk advised the representatives of the several underwriters in connection with the $96 million initial public offering by Mission Produce, Inc. of 8,000,000 shares of its…
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
EPIC Y-Grade refinancing and credit facility amendments
We advised an ad hoc group of lenders on the transaction
Biondvax Pharmaceuticals $100 million at-the-market offering
Davis Polk advised BiondVax Pharmaceuticals Ltd. in connection with its registered at-the-market offering of shares of its American depositary shares for up to a maximum offering price of …
Boa Vista SCPC R$1.9 billion IPO
Davis Polk advised the joint bookrunners in connection with the initial public offering by Boa Vista Serviços S.A. and the selling shareholders of 154,650,184 common shares for an…
Carvana $1.1 billion senior notes offering
Davis Polk advised the representative of the initial purchasers on a Rule 144A/Regulation S debt offering by Carvana Co. of $500 million aggregate principal amount of its 5.625%…
Fresnillo $850 million senior notes offering and concurrent tender offer
Davis Polk advised the initial purchasers in connection with the Rule 144A/Regulation S offering by Fresnillo plc of 4.250% senior notes due 2050 in the aggregate amount of $850…
Fuelcell Energy $105.1 million follow-on offering
Davis Polk advised the representatives of the several underwriters in connection with FuelCell Energy, Inc.’s $105.1 million follow-on offering of 50,025,000 shares of common…
Qell Acquisition $380 million IPO
Davis Polk advised the representatives of the several underwriters in connection with the initial public offering of 33,000,000 units of Qell Acquisition Corp., for aggregate proceeds…
$675 million financing for KPS Capital Partners acquisition of AM General
Davis Polk advised the initial purchasers on a Rule 144A/Regulation S offering by PM General Purchaser LLC of $600 million aggregate principal amount of its 9.500% senior secured notes…
Coloplast acquisition of a minority interest in Francis Medical
Davis Polk advised Coloplast A/S in connection with its strategic equity investment in Francis Medical, Inc.Coloplast A/S is a Danish medical device company that develops products and…